Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
about
Current perspectives on the immunopathogenesis of systemic sclerosisHigh IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.Immune-Mediated Repair: A Matter of Plasticity.The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesUpdate on macrophages and innate immunity in sclerodermaFrequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in sclerodermaTh17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety.Efficacy and safety of etanercept in chronic immune-mediated disease.Potential use of TNF-α inhibitors in systemic sclerosis.The role of the acquired immune response in systemic sclerosis.T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.The many faces of interleukin-17 in inflammatory skin diseases.Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells.Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.IL-17 in the rheumatologist's line of sight.A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.IL-17 and related cytokines involved in systemic sclerosis: Perspectives.Current perspectives on the role of CD8+ T cells in systemic sclerosis.Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist's, Clinician's, and Patient's Perspective.IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
P2860
Q26741264-07C82649-DDA5-4C90-BA9B-E023A31B7F96Q34066564-DFC3232F-8AAB-44AC-B762-0D744D279C1CQ34556402-54A0D09B-4F5E-4A64-B646-F6277BEECD42Q36249305-21DF3EEF-4141-4820-AE75-CE3BB36B0947Q36607887-3E77F3A3-C7BA-4F79-97A8-BD2FA0AB7FCDQ36871425-807B58A9-B6B3-4DB5-8208-FD85F472B94AQ37691158-A9BBED73-B388-45E2-B0AC-D32F73E95E0DQ38154628-E9CC4F78-7A06-4AB6-8AF0-562487906208Q38175430-86F7F821-6E06-497E-953E-1F135E27BDB0Q38198080-33662477-9E78-4A14-8F2E-7365FDD4BE28Q38206817-AC73E763-FEA2-44F3-990B-66E0C6BA45A4Q38543690-EDCB20F2-5D4C-4B70-B7E2-B7662FED26B2Q38601631-5EEC7E79-E28A-4CB5-9AFF-2617CC078E3BQ38818542-69B44E53-4E29-41A6-B402-46A2750C22F6Q40924512-E50BEDE3-295C-4DE0-8396-3E6FC98E764BQ41519827-2E3BB34D-A524-40BE-AD93-91FDF22BCAFCQ41890076-978C74D3-B1CA-4093-9AEE-E81459F2507AQ42615760-8AB97985-407F-4FBD-A064-6430335680F4Q47651642-67981E9B-D72E-4A90-89DB-04871DBA4A46Q47774368-78CFE72B-F1CC-4049-9758-EDCA42FBE672Q49507866-DDFBEB1E-8E29-4B40-A0B0-AE7443310AD7Q50230077-90BC4EA6-6D7A-4B8C-AA82-0A027E41FEFBQ52911127-2BAB0347-DB35-47C0-80BC-A347706720C1Q52993153-DC9CC820-BA9F-4246-BCA5-15E5B9635E52Q53512767-AFBC0F58-E8F6-464C-9882-790D0408C2E1Q58785737-BCCD8D81-CEA0-4752-AD5E-7079B4B7B1B1
P2860
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@en
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@nl
type
label
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@en
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@nl
prefLabel
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@en
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@nl
P2093
P2860
P356
P1476
Interleukin-17A+ cell counts a ...... he extent of skin involvement.
@en
P2093
Carlo Chizzolini
Elena Raschi
Elisa Montanari
Lionel Fontao
Marie-Elise Truchetet
Nicolò-Costantino Brembilla
Paola Lonati
Silvana Zeni
P2860
P304
P356
10.1002/ART.37860
P577
2013-05-01T00:00:00Z